Switch to:
Onyx Pharmaceuticals, Inc. (NAS:ONXX)
EV/Revenue
0.00 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Onyx Pharmaceuticals, Inc.'s enterprise value is \$0.0 Mil. Onyx Pharmaceuticals, Inc.'s revenue for the trailing twelve months (TTM) ended in Jun. 2013 was \$515.9 Mil. Therefore, Onyx Pharmaceuticals, Inc.'s EV/Revenue ratio for today is 0.00.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Onyx Pharmaceuticals, Inc.'s stock price is \$124.70. Onyx Pharmaceuticals, Inc.'s revenue per share for the trailing twelve months (TTM) ended in Jun. 2013 was \$7.35. Therefore, Onyx Pharmaceuticals, Inc.'s P/S Ratio for today is 16.97.

Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Onyx Pharmaceuticals, Inc.'s EV/Revenue for today is calculated as:

 EV/Revenue = Enterprise Value (Today) / Revenue (TTM) = 0.000 / 515.948 = 0.00

Onyx Pharmaceuticals, Inc.'s current Enterprise Value is \$0.0 Mil.
Onyx Pharmaceuticals, Inc.'s Revenue for the trailing twelve months (TTM) ended in Jun. 2013 was 89.511 (Sep. 2012 ) + 127.919 (Dec. 2012 ) + 145.492 (Mar. 2013 ) + 153.026 (Jun. 2013 ) = \$515.9 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Onyx Pharmaceuticals, Inc.'s P/S Ratio for today is calculated as:

 P/S Ratio = Share Price (Today) / Revenue Per Share (TTM) = 124.70 / 7.347 = 16.97

Onyx Pharmaceuticals, Inc.'s share price for today is \$124.70.
Onyx Pharmaceuticals, Inc.'s Revenue Per Share for the trailing twelve months (TTM) ended in Jun. 2013 was 1.307 (Sep. 2012 ) + 1.895 (Dec. 2012 ) + 2.047 (Mar. 2013 ) + 2.098 (Jun. 2013 ) = \$7.35.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Onyx Pharmaceuticals, Inc. Annual Data

 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 ev2rev 0.00 1,864.89 826.95 813.93 28.70 33.72 5.68 5.91 5.41 13.22

Onyx Pharmaceuticals, Inc. Quarterly Data

 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 ev2rev 5.59 5.71 5.57 5.41 4.35 8.46 11.46 13.22 13.23 11.17
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)